MedPath

Effects of L / N type Ca channel blocker cilnicipine on heart rate and QT time during hemodialysis

Not Applicable
Recruiting
Conditions
endstage chronic kidney disease
Registration Number
JPRN-UMIN000023201
Lead Sponsor
Department of Nephrology and Dialysis, Moriguchi Keijinnkai Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

acute myocardial infarction or cerebrovascular disease occurring within a half year and atrial fibrillation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in heart rate or QTc during one hemodialysis session after taking L/N Ca blocker for 4 weeks
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath